Bmy annual report
WebGet the annual and quarterly balance sheet of Bristol-Myers Squibb Company (BMY) including details of assets, liabilities and shareholders' equity. WebApr 13, 2024 · Bristol Myers Squibb (BMY Quick Quote BMY - Free Report) closed at $70.69 in the latest trading session, marking a +0.68% move from the prior day. This change lagged the S&P 500's 1.33% gain on ...
Bmy annual report
Did you know?
WebFeb 4, 2024 · Reports Fourth Quarter Revenues of $12.0 Billion; Full-Year Revenues of $46.4 Billion Posts Fourth Quarter Earnings Per Share of $1.07 and Non-GAAP EPS of $1.83; Posts Full-Year Earnings Per Share of $3.12 and Non-GAAP EPS of $7.51 Delivers Strong Revenues for Eliquis, Immuno-Oncology and New Product Portfolios Advances … WebFeb 13, 2015 · Ticker: BMY CIK: 14272 Form Type: 10-K Annual Report Accession Number: 0000014272-15-000055 Submitted to the SEC: Fri Feb 13 2015 9:38:42 AM EST Accepted by the SEC: Fri Feb 13 2015 Period: Wednesday, December 31, 2014 Industry: Pharmaceutical Preparations External Resources: Stock Quote
WebLaunching new medicines and growing our business. In 2024, we had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion, generating GAAP EPS of $3.12 and increasing non-GAAP EPS * by 17 percent to $7.51. We had strong performance across our in-line brands and our New Product Portfolio, which … WebActual results may differ from those indicated as a result of various important factors, including those discussed in the company’s most recent annual report on Form 10-K and reports on Form 10-Q and Form 8-K. These documents are available from the SEC, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.
WebBristol Myers Squibb 2024 Financial Report Table of Contents Management’s Discussion and 2 Analysis of Financial Condition and Results of Operations Quantitative and … WebBristol-Myers Squibb Company has appointed EQ Shareowner Services as Administrator for the plan. The plan is not sponsored or administered by Bristol-Myers Squibb Company. Form 10-K For a free copy of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, contact: Corporate Secretary* Bristol-Myers Squibb …
WebBristol-Myers Squibb Co (NYSE:BMY) Bristol-Myers Squibb Co. BMY Regular Dividend: BMY began trading ex-dividend on 04/06/23. A $0.57 dividend will be paid to shareholders of record as of 04/10/23.
WebActual results may differ from those indicated as a result of various important factors, including those discussed in the company’s most recent annual report on Form 10-K … lady\\u0027s-thistle flWebquarter was approximately $132,442,510,032. Bristol-Myers Squibb has no non-voting common equity. At February 1, 2024, there were 2,240,475,153 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE: Portions of the definitive proxy statement for the registrant’s Annual Meeting of Shareholders to lady\\u0027s-thistle fuWebOct 20, 2024 · Bristol Myers Squibb Co. Annual stock financials by MarketWatch. View the latest BMY financial statements, income statements and financial ratios. property for sale van zandt county txWeb2024 Annual Report. Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for … property for sale valencia coastWebOct 7, 2024 · Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on … lady\\u0027s-thistle ftWebEnvironmental, Social and Governance Report. Bristol Myers Squibb’s 2024 ESG Report discusses our progress toward sustainability against 16+ indicators in accordance with the BioPharma Alliance, as well as GRI, NBIM and SASB. Download Report PDF >. property for sale vancouver island bcWebAnnual Report 2024 - Bristol-Myers Squibb. “2024 was an important year for our company, one with significant clinical and regulatory achievements that broadened our portfolio, … lady\\u0027s-thistle g9